Global Medical Polyurethane Market Size, Share, and COVID-19 Impact Analysis, By Type (Liquid Polyurethane, Biostable Polyurethane, and Thermoplastic Polyurethane), By Application (Vascular access devices, Disposable surgical supplies, Cardiovascular treatment devices, Urological devices, Tracheotomy devices, Dialysis devices, Feeding tubes, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Medical Polyurethane Market Insights Forecasts to 2035

• The Global Medical Polyurethane Market Size Was Estimated at USD 1.9 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.76% from 2025 to 2035
• The Worldwide Medical Polyurethane Market Size is Expected to Reach USD 3.9 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Spherical Insights and Consulting, The Global Medical Polyurethane Market Size was worth around USD 1.9 Billion in 2024 and is predicted to grow to around USD 3.9 Billion by 2035 with a compound annual growth rate (CAGR) of 6.76% from 2025 and 2035. The market for medical polyurethane has a number of opportunities to grow due to the need for cutting edge medical equipment and materials is rising as a result of the aging of the world's population and the rising incidence of chronic illnesses. Because of their biocompatibility, flexibility, and durability, medical polyurethanes are crucial for use in implantable devices, drug delivery systems, and wound care.   

Report Coverage

This research report categorizes the medical polyurethane market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the medical polyurethane market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the medical polyurethane market. 

Driving Factors

The medical polyurethane market is driven by the market for medical polyurethane offers a wealth of chances for expansion and creativity. A significant opportunity is the growing need for cutting edge wound care solutions. The need for creative and efficient wound care treatments is increasing as the incidence of chronic wounds, such as pressure sores and diabetic ulcers, keeps rising. Polyurethane is a perfect material for creating cutting edge wound care solutions because of its exceptional moisture control, breathability, and barrier protection. The market is anticipated to rise as a result of ongoing research and development initiatives to produce wound care products that are more effective and patient friendly.    

Restraining Factors

The medical polyurethane market is restricted by factors like the strict regulatory standards for medical materials and devices are one of the main obstacles. To guarantee the safety and effectiveness of polyurethane products in medical applications, a thorough testing and validation process is required due to the strict regulatory environment.

Market Segmentation

The medical polyurethane market share is classified into type and application.  

• The thermoplastic polyurethane segment dominated the market in 2024, accounting for approximately 41% and is projected to grow at a substantial CAGR during the forecast period.

Based on the type, the medical polyurethane market is divided into liquid polyurethane, biostable polyurethane, and thermoplastic polyurethane. Among these, the thermoplastic polyurethane segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The segment is driven by medical equipment that frequently uses melt processable polyurethanes, sometimes referred to as thermoplastic polyurethanes or polyurethane elastomers. Catheters frequently require polyurethanes that are biocompatible, robust, and durable. The market is expected to develop due to the growing usage of catheters, such as multilumen, central venous access, and over-the-needle IV catheters, which are frequently composed of melt processable polyurethanes. Another use that benefits from the flexibility of thermoplastic polyurethanes is wound dressings.   

• The cardiovascular treatment devices segment accounted for the largest share in 2024, accounting for approximately 68.8% and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the medical polyurethane market is divided into vascular access devices, disposable surgical supplies, cardiovascular treatment devices, urological devices, tracheotomy devices, dialysis devices, feeding tubes, and others. Among these, the cardiovascular treatment devices segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The dominance is due to the new surgical implants made of biomedical polyurethanes can help eliminate some acute and long-term health issues. The cardiovascular industry and other biomedical disciplines make extensive use of polyurethanes due to their excellent mechanical qualities and biocompatibility.  

Regional Segment Analysis of the Medical Polyurethane Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share, representing nearly 40% of the medical polyurethane market over the predicted timeframe.

North America is anticipated to hold the largest share, representing nearly 40% of the medical polyurethane market over the predicted timeframe. In the North American market, the market is rising due to the strong ecosystem, with both cutting edge startups and major industrial heavyweights well-represented. The demand for medical polyurethane has been driven by the existence of significant market participants, a strong healthcare infrastructure, and high healthcare spending. Due to its well established healthcare system and strong demand for cutting edge medical items, the United States, in particular contributes significantly to the industry. The adoption of cutting edge medical technologies and ongoing investments in healthcare innovation are driving market expansion in this area.  

Asia Pacific is expected to grow at a rapid CAGR, representing nearly 8.1% in the medical polyurethane market during the forecast period. The Asia Pacific area has a thriving market for medical polyurethane driven by rising awareness of cutting edge medical treatments, a growing population, and rising healthcare investments. With a strong demand for medical equipment and wound care products, nations like China, India, and Japan are major market contributors. Major factors propelling market expansion in this region are the expanding emphasis on improving patient care and the developing healthcare infrastructure.

Europe, with its sophisticated healthcare system and advances in medical technology, is another significant market for medical polyurethane. Due to the strong demand for medical equipment and wound care products, nations like Germany, France, and the United Kingdom are major market contributors. The demand for polyurethane products in this region is being driven by the growing emphasis on patient comfort and safety, as well as the adoption of cutting-edge medical solutions.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the medical polyurethane market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• BASF SE
• Covestro AG
• Huntsman Corporation
• Lubrizol Corporation
• Wanhua Chemical Group
• Dow Chemical Company
• Evonik Industries
• Cardinal Health
• Asahi Kasei Corporation
• Mitsui Chemicals
• Solvay S.A.
• Kraton Polymers
• Meril Life Sciences
• Trinseo S.A.
• Stryker Corporation
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the medical polyurethane market based on the below-mentioned segments: 

Global Medical Polyurethane Market, By Type 

• Liquid Polyurethane
• Biostable Polyurethane
• Thermoplastic Polyurethane

Global Medical Polyurethane Market, By Application

• Vascular access devices
• Disposable surgical supplies
• Cardiovascular treatment devices
• Urological devices
• Tracheotomy devices
• Dialysis devices
• Feeding tubes
• Others

Global Medical Polyurethane Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa